AI APR / PQR — from live data, not a re-typed spreadsheet.
V5 assembles the Annual Product Review from live V5 data: batches, deviations, CAPAs, complaints, stability, changes, returns. The AI drafts the narrative sections, flags trends and out-of-trend results — and the QA reviewer signs the finished document.
What breaks without this.
APR is a 200-400 hour project per product
Data pulls from 6 systems, hand-typed narrative, tables re-built each year.
The report is stale on delivery
By the time it is signed, the trend it documented is 3 months old.
Cross-product trends stay invisible
Each APR is written in isolation; systemic trends across the portfolio never surface.
Records-by-execution. Compliance, by design.
Data pull is a query, not a project
Batches, deviations, CAPAs, complaints, stability, changes — all live V5 data, all correctly filtered by product and period.
AI drafts every narrative section
Manufacturing summary, deviation summary, stability commentary, complaint summary, CAPA effectiveness — first-draft in minutes, cited to source.
Out-of-trend flagged, not just tabulated
Yield, cycle-time, deviation rate and stability drift are flagged against control limits, not just plotted.
Consistent format year on year
Structured template applies to every product; changes to the template propagate, so year-on-year comparability is preserved.
Portfolio-wide trend layer
Cross-product trends run alongside — systemic issues surface before the site QA writes the same finding for the fifth product.
What to look for when you're buying.
APR platforms live or die on data-lineage and consistency. Criteria that separate a real product-review tool from a report generator.
Live data or extract-based?
What it tests: Does the APR read live V5 data or does someone rebuild an extract?
Why it matters: Extracts drift.
V5: Live V5 data, filtered per product and period.
Consistent template year-on-year
What it tests: Is the template versioned so year-on-year comparability is preserved?
Why it matters: Regulators compare year-to-year.
V5: Versioned template with lineage.
OOT flagging, not just plotting
What it tests: Are out-of-trend results flagged against control limits?
Why it matters: Plots that don't flag get skimmed.
V5: OOT flagged with statistical basis.
Multi-site aggregation
What it tests: Does it handle multi-site products with per-site sub-summary and cross-site comparison?
Why it matters: Multi-site is the norm.
V5: Multi-site native.
Portfolio trends
What it tests: Are cross-product trends surfaced alongside per-product APR?
Why it matters: Systemic issues hide in per-product isolation.
V5: Portfolio trend layer runs alongside.
Human sign-off preserved
What it tests: Does QA still sign the APR?
Why it matters: APR is a signed record; AI drafts, human signs.
V5: QA e-signature is the closure event.
Spreadsheet vs legacy QMS vs V5.
AI APR vs a hand-built APR and vs a legacy APR module.
| Capability | Spreadsheet | Legacy QMS | V5 Ultimate |
|---|---|---|---|
| Data source | 6-system pull | Snapshot extract | Live V5 data |
| Template versioning | Ad-hoc | Sometimes | Versioned with lineage |
| OOT flagging | Manual | Basic | Statistical with citation |
| Multi-site | Multiple reports | Manual merge | Native aggregation |
| Portfolio trends | None | Separate quarterly | Alongside per-product |
The clauses, verbatim — and how V5 answers each.
APR / PQR clauses across FDA, EU and ICH.
Written records required by this part shall be maintained so that data therein can be used for evaluating, at least annually, the quality standards of each drug product.
V5: Live V5 data is the record; annual evaluation is a scheduled export.
Regular periodic or rolling quality reviews of all authorised medicinal products... should be conducted with the objective of verifying the consistency of the existing process...
V5: PQR is generated on the customer's cadence — quarterly, semi-annually, annually — from the same live spine.
Process performance and product quality monitoring system.
V5: APR is the annual snapshot of the same monitoring surface that CPV runs continuously.
Regular quality reviews of APIs should be conducted with the objective of verifying the consistency of the process.
V5: API APR uses the API-specific template with ICH Q7 sectioning.
Step by step on the floor.
APR runs on a schedule; the reviewer's role changes from author to editor.
- 1Setup
Template mapped
Customer's APR template mapped to V5 sections; per-product overrides captured.
- 2Monthly
Rolling summaries updated
Monthly summaries update the APR draft continuously.
- 3Cadence
Draft generated
On cadence (annually / semi-annually), full draft generated with OOT flags.
- 4Review
QA edits, challenges, adds narrative
Reviewer works on the draft, not from scratch.
- 5Signoff
e-signature closes the APR
QA signs; APR is a signed record with full data lineage.
The math, with the assumptions visible.
APR ROI is dramatic because the baseline is so labour-heavy.
Hours per product per year
Data-pull and drafting are both machine work.
Data-as-of lag
Live query, not extract.
Cross-product trend visibility
Portfolio layer runs alongside.
APR alone frequently justifies the AI-suite investment for pharma sites at 5+ products.
What changed on the floor.
Setting
A generics manufacturer with 47 marketed products across 3 sites.
Before
APR programme absorbed ~10,000 hours per year; findings surfaced too late to close inside the annual cycle.
After
First full year on V5: APR programme runs at ~1,400 hours; portfolio trend layer surfaced a shared stabiliser-supplier issue that would previously have taken two more annual cycles to spot.
Proof points
- APR labor drops from hundreds of hours to tens
- Report reflects data as of report date, not last quarter
- Every narrative claim cites the source batch, deviation or CAPA
- Portfolio-wide trends run alongside per-product APR
Built to satisfy
- 21 CFR 211.180(e) (annual product review)
- EU GMP Chapter 1 §1.10 (Product Quality Review)
- ICH Q7 §2.5 (product quality review)
- ICH Q10 §3.2.3 (process performance and product quality monitoring)
- PIC/S PE 009 Chapter 1 (PQR)
Related on V5
Frequently asked questions
Does the AI sign the APR?+
No. AI drafts; the QA reviewer challenges and e-signs. The signature block, review evidence and closure remain human.
How does this handle multi-site products?+
Product master ties to sites; the APR pulls from every producing site with per-site sub-summary and cross-site comparison.
Can we keep our current APR template?+
Yes — customer template applies. The AI fills the sections; the layout, headers and appendices stay yours.
See V5 on your own line.
Free trial, no card. Live in 7 days with guided onboarding.